Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
April 16, 2021 at 05:40 pm IST
Share
Hunan Jiudian Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 978.159 million compared to CNY 924.061 million a year ago. Operating income was CNY 91.719 million compared to CNY 62.895 million a year ago. Net income was CNY 82.259 million compared to CNY 55.065 million a year ago. Basic earnings per share from continuing operations was CNY 0.35 compared to CNY 0.23 a year ago.
Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Companyâs products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.
HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. 
